Titlebook: Endocannabinoid Signaling; Methods and Protocol Mauro Maccarrone Book 2023Latest edition The Editor(s) (if applicable) and The Author(s), u

Nonchalant

書目名稱Endocannabinoid Signaling影響因子(影響力)




書目名稱Endocannabinoid Signaling影響因子(影響力)學(xué)科排名




書目名稱Endocannabinoid Signaling網(wǎng)絡(luò)公開度




書目名稱Endocannabinoid Signaling網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Endocannabinoid Signaling被引頻次




書目名稱Endocannabinoid Signaling被引頻次學(xué)科排名




書目名稱Endocannabinoid Signaling年度引用




書目名稱Endocannabinoid Signaling年度引用學(xué)科排名




書目名稱Endocannabinoid Signaling讀者反饋




書目名稱Endocannabinoid Signaling讀者反饋學(xué)科排名

高深莫測

推測

六個才偏離

Extraction and Simultaneous Quantification of Endocannabinoids and Endocannabinoid-Like Lipids in Bhidonoyl glycerol (2-AG), and endocannabinoid-like lipids such as palmitoyl ethanolamide (PEA) and oleoyl ethanolamide (OEA), as well as arachidonic acid (AA) from biological tissues using liquid–liquid extraction method and simultaneous quantification by liquid chromatography multiple reaction monitoring (LC/MRM).

Crepitus

貨物

Distribution Models and Functions,olize these lipids is presented here, in orderto put in a better perspective, the relevance of methodologies that help to disclose molecular details of eCB signaling in health and disease. Proper methodological approaches form also the basis for a more rationale and effective drug design and therapeutic strategy to combat human disorders.

貨物

https://doi.org/10.1007/978-3-662-05409-3hput radioligand binding assay that allows to evaluate efficacy and potency of different compounds, which might represent the basis for the development of new drugs that target CB.-dependent human diseases.

啞巴

Materials and Device Degradation,of .-arachidonoylethanolamine (AEA) and 2-arachidonoylglycerol (2-AG) in the sites where these major eCBs are indeed needed. This chapter will briefly review some preclinical and clinical evidence for the therapeutic potential of ECS pharmacological manipulation.

疾馳

慢跑鞋

Assay of CB1 Receptor Binding,hput radioligand binding assay that allows to evaluate efficacy and potency of different compounds, which might represent the basis for the development of new drugs that target CB.-dependent human diseases.